Division of Neurology, Sunnybrook Health Science Center, University of Toronto, Canada;
Department of Neurology, University of Texas Health Science Center, Houston, TX; …

During recent years thrombolytic trials in cerebral ischemia have indicated that time, both
from the onset of symptoms to hospitalisation and from first examination to treatment …

Background To reliably identify patients at risk for symptomatic hemorrhagic transformation
(SHT), future trials of thrombolysis for acute ischemic stroke might use a vascular imaging …

El infarto cerebral agudo representa una emergencia clínica, potencialmente reversible si
se trata con trombolisis durante las primeras 3 a 6 horas de evolución. La trombolisis tiene …

Purpose: Perfusion defects can be demonstrated reliably at an early stage with regional
cerebral blood flow studies using SPECT. The administration of thrombolytic therapy in …

Purpose To compare the diagnostic yield of CT scan and perfusion SPECT on admission
and its prognostic value in clinical outcome. Methods 25 ischemic stroke cases were studied …

Purpose—The aim of our study was twofold: to determine the frequency and magnitude of
perfusion defect in stroke patients who qualify for rtPA therapy within 3 hours of stroke onset …

One of the major reasons for interest in using single-photon emission CT (SPECT) for
managing ischemia is that it is a reliable and inexpensive functional neuroimaging modality …

To address the issue of whether single-photon emission computed tomography (SPECT)
may add useful topographic information to neurologic examination in clinical practice, we …

New therapeutic interventions for acute ischemic stroke are aimed at improving cerebral
blood flow in the first 3 to 6 hours after symptom onset. Single-photon emission-computed …